Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Head & Neck|May 15, 2014
Safety and efficacy of hypofractionated stereotactic body reirradiation in head and neck cancer: Long-term follow-up of a large seriesMarie-Adele S Kress, Neilayan Sen, Keith R Unger, et al.
Molecular Pharmacology|July 28, 2009
Identification of compounds that correlate with ABCG2 transporter function in the National Cancer Institute Anticancer Drug ScreenJohn F Deeken, Robert W Robey, Suneet Shukla, et al.
Neuropediatrics|June 22, 2019
EPG5 Variants with Modest Functional Impact Result in an Ameliorated and Primarily Neurological Phenotype in a 3.5-Year-Old Patient with Vici SyndromeMegan S Kane, Jia Zhao, Julie Muskett, et al.
Journal of Bronchology & Interventional Pulmonology|October 21, 2022
Effectiveness of an Electronic Medical Record-Based Recognition Tool for the Identification of Incidental Pulmonary NodulesAmit K Mahajan, Nancy Collar, Mahwish Bari, et al.
Cancer|February 3, 2015
A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor malignanciesJohn F Deeken, Hongkun Wang, Deepa Subramaniam, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 2010
Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancerKeith R Unger, Christopher E Lominska, John F Deeken, et al.
Cancer Research Communications|June 4, 2025
Real-world Data on Risk Factors for Emergency Department Visits to Treat Outpatient Chemotherapy-Associated ToxicitiesSanja Karovic, Erik Dvergsten, Chiara Pierattini, et al.
Cancer Chemotherapy and Pharmacology|January 1, 2013
A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignanciesJohn F Deeken, Rebecca Slack, Glen J Weiss, et al.
Nature Genetics|March 7, 2018
Germline de novo mutation clusters arise during oocyte aging in genomic regions with high double-strand-break incidenceJakob M Goldmann, Vladimir B Seplyarskiy, Wendy S W Wong, et al.
Head & Neck|March 12, 2014
Effect of multimodality treatment on overall survival for patients with metastatic or recurrent HPV-positive head and neck squamous cell carcinomaJohn F Deeken, Kenneth Newkirk, K William Harter, et al.
Pageof 4